1. Home
  2. KDLY vs RDHL Comparison

KDLY vs RDHL Comparison

Compare KDLY & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KDLY
  • RDHL
  • Stock Information
  • Founded
  • KDLY 2019
  • RDHL 2009
  • Country
  • KDLY United States
  • RDHL Israel
  • Employees
  • KDLY N/A
  • RDHL N/A
  • Industry
  • KDLY
  • RDHL Biotechnology: Pharmaceutical Preparations
  • Sector
  • KDLY
  • RDHL Health Care
  • Exchange
  • KDLY NYSE
  • RDHL Nasdaq
  • Market Cap
  • KDLY 7.8M
  • RDHL 8.6M
  • IPO Year
  • KDLY 2024
  • RDHL N/A
  • Fundamental
  • Price
  • KDLY $1.12
  • RDHL $6.50
  • Analyst Decision
  • KDLY
  • RDHL
  • Analyst Count
  • KDLY 0
  • RDHL 0
  • Target Price
  • KDLY N/A
  • RDHL N/A
  • AVG Volume (30 Days)
  • KDLY 1.0M
  • RDHL 21.6K
  • Earning Date
  • KDLY 02-03-2025
  • RDHL 01-03-2025
  • Dividend Yield
  • KDLY N/A
  • RDHL N/A
  • EPS Growth
  • KDLY N/A
  • RDHL N/A
  • EPS
  • KDLY N/A
  • RDHL N/A
  • Revenue
  • KDLY $2,875,400.00
  • RDHL $3,707,000.00
  • Revenue This Year
  • KDLY N/A
  • RDHL $224.90
  • Revenue Next Year
  • KDLY N/A
  • RDHL $82.69
  • P/E Ratio
  • KDLY N/A
  • RDHL N/A
  • Revenue Growth
  • KDLY N/A
  • RDHL N/A
  • 52 Week Low
  • KDLY $0.65
  • RDHL $6.00
  • 52 Week High
  • KDLY $4.20
  • RDHL $40.50
  • Technical
  • Relative Strength Index (RSI)
  • KDLY N/A
  • RDHL 38.21
  • Support Level
  • KDLY N/A
  • RDHL $6.00
  • Resistance Level
  • KDLY N/A
  • RDHL $7.30
  • Average True Range (ATR)
  • KDLY 0.00
  • RDHL 0.51
  • MACD
  • KDLY 0.00
  • RDHL -0.09
  • Stochastic Oscillator
  • KDLY 0.00
  • RDHL 21.10

About KDLY KINDLY MD INC

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

Share on Social Networks: